Pharmacokinetics of Atogepant in Healthy Lactating Female Participants: Results from a Phase 1 Lactation Study
The cumulative mean amount of atogepant recovered in breast milk over 24 h following a 60-mg dose was 0.009 mg, with a RID of 0.19%. CLINICAL TRIAL REGISTRATION: NCT05892757; https://clinicaltrials.gov/study/NCT05892757 .
Authors
- Ramesh Boinpally (ORCID: https://orcid.org/0000-0001-8267-9210)
- Jonathan H. Smith (ORCID: https://orcid.org/0000-0002-2798-6805)
- Joel M. Trugman (ORCID: https://orcid.org/0000-0002-2376-8878)
- Raquel Ferreira (ORCID: https://orcid.org/0000-0001-5525-1032)
Institutions
- AbbVie (United States) (US)
Publication Details
- Journal
- Neurology and Therapy
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1007/s40120-025-00772-4
- Citations
- 2
- Primary Topic
- Maternal Mental Health During Pregnancy and Postpartum
- Type
- article
- Field-Weighted Citation Impact
- 3.76
Funders
- AbbVie